Cologne, August 22th, 2016 – AYOXXA Biosystems GmbH, an international biotechnology company, and Märzhäuser Wetzlar GmbH & Co KG, a leading precision equipment manufacturer, joined forces to develop a dedicated benchtop device for the analysis of LUNARIS™ Multiplex assays. The AYOXXA Reader AR01 expands the technology platform to offer researchers a complete, flexible and user-friendly system for multiprotein analysis. The device was approved for routine laboratory work use in biomedical research.
The instrument allows the fluorescence-based readout of a LUNARIS™ Multiplex assay with up to 384 samples on a microtiter plate format in less than one hour. Readout is fully automated using a self-developed control software which complements the already available analysis solution. The latter application processes the acquired data for easy, streamlined biomarker quantification and detailed reporting.
“With Märzhäuser, we are pleased to have found a development and manufacturing partner for the AYOXXA Reader AR01 that has a solid international reputation based on high competence and quality standards,” comments Dr. Andreas Schmidt, CEO of AYOXXA. “Our close collaboration has facilitated the quick and efficient development of a very important element of our technology platform.”
“Working with AYOXXA allowed us to apply our precise micro-positioning systems and controllers, as well as the know-how in microscopy for the development of innovative analysis systems,” comments Günter Märzhäuser, an Executive Director of Märzhäuser Wetzlar GmbH & Co. KG. “As a result, we are driving the development of sustainable future markets.”
Please follow this link to read the original article.